Benidipine hydrochloride
CAS No. 91599-74-5
Benidipine hydrochloride( (±)-Benidipine | KW-3049 )
Catalog No. M16577 CAS No. 91599-74-5
Benidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 34 | Get Quote |
|
| 50MG | 45 | Get Quote |
|
| 100MG | 63 | Get Quote |
|
| 200MG | 105 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBenidipine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.
-
DescriptionBenidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.
-
In VitroWestern Blot Analysis Cell Line:Murine PBMCs Concentration:1 μM Incubation Time:7 days Result:Increased the expression of phosphorylated Akt on serine-473.Cell Proliferation Assay Cell Line:Mesangial cells Concentration:0.1-10 μM Incubation Time:48 h Result:Inhibited the progression of the cell cycle in a dose-dependent manner.
-
In VivoAnimal Model:MI/R rabbits model Dosage: 3-10 μg/kg Administration:i.v.Result:Caused a significant decrease in HR ( heart rate), MABP (mean arterial blood pressure), and PRI (pressure-rate index) at 10 μg/kg.Decreased apoptotic positive cells to 7.4% at 3 μg/kg.Animal Model:Renovascular hypertensive rats (RHR) model Dosage:5 mg/kg Administration:i.v.Result:Decreased the blood pressure and coronary vascular resistance index.Increased nitrite production and eNOS mRNA expression and the coronary flow at rest, the capillary density.Animal Model:Rat heart model Dosage:1-10 mg/kg Administration:p.o.Result:Increased the post-ischemic recovery of LVDP and LV dP/dt max (LVDP: 87.5±10.1 vs 64.6±11.9%;LV dP/dt max: 97.8±10.4 vs 70.2±15.7%) at 3 mg/kg.
-
Synonyms(±)-Benidipine | KW-3049
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR (L861Q)| c-Src| c-Yes| Lck| Lyn
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number91599-74-5
-
Formula Weight542.03
-
Molecular FormulaC27H32ClN5O5
-
Purity>98% (HPLC)
-
SolubilityDMSO: 8 mg/mL (14.75 mM)
-
SMILESCC1=C([C@H](C(=C(N1)C)C(=O)O[C@@H]2CCCN(C2)CC3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chang YM, Oncogene, 2008, 27(49), 6365-6375.
molnova catalog
related products
-
Lapatinib
A reversible, selective dual tyrosine kinase inhibitor of both EGFR and ErbB2 with IC50 of 10.8 and 9.2 nM in cell-free assays, respectively.
-
AZ5104
AZ5104, the demethylated metabolite of AZD-9291, is a potent EGFR inhibitor.
-
Canertinib dihydroch...
A potent, irreversible, orally available pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 7.5 nM and 9.0 nM in autophosphorylation assay.
Cart
sales@molnova.com